...
机译:Eltompopag在患有严重MyH9 Myh9-Helely血小板减少症的患者手术中制备手术
Department of Internal MedicineIRCCS Policlinico San Matteo Foundation and University of PaviaPavia;
Department of Internal MedicineIRCCS Policlinico San Matteo Foundation and University of PaviaPavia;
Department of Internal MedicineIRCCS Policlinico San Matteo Foundation and University of PaviaPavia;
Department of MedicineUniversity of PerugiaPerugia Italy;
Department of Internal MedicineIRCCS Policlinico San Matteo Foundation and University of PaviaPavia;
Department of Internal MedicineIRCCS Policlinico San Matteo Foundation and University of PaviaPavia;
机译:Eltompopag在患有严重MyH9 Myh9-Helely血小板减少症的患者手术中制备手术
机译:Eltrombopag用于治疗源自MYH9突变的遗传性血小板减少症。
机译:β地中海贫血重症血小板减少症患者的新型MYH9突变
机译:患有无症状严重主动脉狭窄患者的决策,先发型主动脉瓣置换手术
机译:术前氯己定皮肤准备血管手术的患者
机译:Eltrombopag在难治性重症血小板减少症伴有慢性淋巴细胞白血病相关患者中的长期成功使用从而允许口服抗凝治疗重度心肌病
机译:Eltompopag在患有严重Myh9相关血小板减少症的患者手术中制备手术